Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor.
about
Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signalingProstate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristicsBevacizumab treatment for advanced breast cancerNeuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesisQuercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cellsDifferential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesisEndothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species.Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptorsElectrical Stimulation of Denervated Rat Skeletal Muscle Retards Capillary and Muscle Loss in Early Stages of Disuse AtrophyImpaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout mice.Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVECReduced vascular endothelial growth factor expression in contusive spinal cord injury.Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis.Prognostic value of VEGF in patients submitted to percutaneous coronary intervention.Effects of resistance training on central blood pressure in obese young menOmega-3 polyunsaturated fatty acids enhance cerebral angiogenesis and provide long-term protection after stroke.Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.Polysaccharides from astragali radix restore chemical-induced blood vessel loss in zebrafishVascular endothelial growth factor: molecular underpinning from development of vasculature to development of disease.Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient.MSCs transplantation with application of G-CSF reduces apoptosis or increases VEGF in rabbit model of myocardial infarctionVascular endothelial growth factor in bronchoalveolar lavage fluid in sulfur mustard exposed lung patients.The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival.Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults.Therapeutic angiogenesis using vascular endothelial growth factor.Circulating vascular growth factors and central hemodynamic load in the community.Transplantation of adult neural progenitor cells transfected with vascular endothelial growth factor rescues grafted cells in the rat brainRegulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1.An Association between Bevacizumab and Recurrent Posterior Reversible Encephalopathy Syndrome in a Patient Presenting with Deep Vein Thrombosis: A Case Report and Review of the Literature.Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiationMechanisms of adverse effects of anti-VEGF therapy for cancer.A fusion protein containing murine vascular endothelial growth factor and tissue factor induces thrombogenesis and suppression of tumor growth in a colon carcinoma modelBevacizumab suppresses neuroblastoma progression in the setting of minimal disease.The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusionTemporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle.Metastatic renal cell carcinoma: the first report of unilateral fundus hemorrhage induced by sorafenibEndothelial injury induces vascular smooth muscle cell proliferation in highly localized regions of a direct contact co-culture system.Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial.
P2860
Q24292998-B6F6BEA9-A5BD-413C-BD63-087B16DDD501Q26773613-A0993072-4F23-499B-98F8-447182C824A7Q27027498-4B0C2F95-6C8D-4134-ACC1-ED10EA94FE2AQ28263245-433DE2AD-F550-49B1-AE3E-5BD259FBEDA7Q28480617-F58AA4D5-012D-4106-BF21-C53CF729CC90Q28570324-6CEE89AE-5E88-426F-B91F-886C104D6948Q30496168-0941EDFF-BE29-4630-BED9-0D19F555B382Q33382103-A4C2520E-4356-485F-8B1A-0473EC5C6720Q33608094-E448A5E8-B278-4839-8B8B-4EAAC8BC6A57Q33632835-9F2D34B6-E422-4FAE-BDD4-17DFFC92126AQ33649600-67F428ED-72EF-45E7-861F-EC821A3154C9Q33767262-2F6E7CBE-9266-4DE3-80D6-C4764E1E5F26Q33904867-5DA76FB7-FC59-4B20-8379-1BC71AEF75E5Q33943400-24A4D081-322D-47E9-913D-FB11385EBFB5Q33992008-1B980B57-1D69-4BCA-91CC-B075B75C4923Q34002094-CEBD567C-35ED-440C-8667-CA6DA9CEB15CQ34088265-48530473-61A7-476A-A995-6A26BA7516E0Q34130059-C6C22D80-A274-4753-8BCB-F4ECF593DF20Q34167150-9EE101E9-55C4-4AA5-A702-DD850CC6124AQ34249810-28C5894A-C6C5-4892-859B-35F20C61B546Q34487244-403E4B5D-B6AB-4B43-A64B-5CA5101BD622Q34962330-6948C796-C765-4011-A0C8-A01C221F28CDQ35324013-186221AB-C25F-4042-864F-7F1EA69846DCQ35544693-D68798E8-6AC4-4E79-B516-674B9AE34BDDQ35740177-EA8B9851-6963-414F-9C6C-F57CF7BD249DQ35799595-CF43EF7D-D18E-406E-8426-6351290A7780Q35814821-1801BA56-ABAF-4D51-B6D1-2C4E7D086681Q35912073-81092C10-E06C-446E-BF43-45233B45D8C8Q36274847-202354E1-FA2A-46C8-AE33-6F854FED0CAAQ36302755-61EECA2B-F866-4E24-AD16-EDBD4863672AQ36454840-CB8464AE-2D4A-4DD2-8343-A43AEFAF6B55Q36489148-A8DF704C-2CF9-4299-9C21-BD677C282EC4Q36609627-FA51CCCB-886E-4B5F-9A6F-EC9A52B0017CQ36800959-04B2FA6E-6BF6-4A78-BC27-63A743AA75F2Q36852400-B7AE7E86-3F82-4E74-8B27-303A4D1AB2A5Q36907325-8BDD84FD-E4D6-45DE-9932-C3065970B9FCQ37223966-77557B5A-3877-44A5-AD85-B159C516426CQ37376498-D06BAD60-2E96-44CC-B526-855F7E7E1367Q37405943-247C0702-370A-4FC0-B76D-E734FC2BC3AAQ37573849-82F815ED-6C04-4DC5-8482-DE7102D77B47
P2860
Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Signaling mechanisms mediating ...... lar endothelial growth factor.
@ast
Signaling mechanisms mediating ...... lar endothelial growth factor.
@en
Signaling mechanisms mediating ...... lar endothelial growth factor.
@nl
type
label
Signaling mechanisms mediating ...... lar endothelial growth factor.
@ast
Signaling mechanisms mediating ...... lar endothelial growth factor.
@en
Signaling mechanisms mediating ...... lar endothelial growth factor.
@nl
prefLabel
Signaling mechanisms mediating ...... lar endothelial growth factor.
@ast
Signaling mechanisms mediating ...... lar endothelial growth factor.
@en
Signaling mechanisms mediating ...... lar endothelial growth factor.
@nl
P1476
Signaling mechanisms mediating ...... lar endothelial growth factor.
@en
P2093
P304
P356
10.1152/AJPCELL.2001.280.6.C1375
P577
2001-06-01T00:00:00Z